Indianapolis, Indiana
Animal health company headquartered in Indianapolis.
Contact details checked September 6, 2026.
Company-issued releases from the past 90 days. Company claims have not been independently verified.
Elanco said it will report third-quarter 2026 financial results on November 6 and hold an earnings call at 8 a.m. Eastern. The company plans to provide a public webcast and a replay through its investor website.
Read original release ↗Elanco announced that its chief executive, chief financial officer and U.S. Pet Health leader would participate in a September 15 fireside chat at the Morgan Stanley healthcare conference. The company said a limited-time replay would follow on its investor website.
Read original release ↗Elanco announced completion of a 25,000-square-foot expansion in Elwood, Kansas, to increase manufacturing capacity for monoclonal antibody products.
Read original release ↗Elanco announced second-quarter financial results, its third-quarter outlook and updated expectations for the full year.
Read original release ↗